Erratum to: "Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the diabetes prevention program" [Metabolism (2016) 65; 764-775].

Erratum to: "Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the diabetes prevention program" [Metabolism (2016) 65; 764-775].
复制标题

勘误:“脂联素的变化解释了生活方式干预引起的 HDL 颗粒的大部分变化,但不能解释糖尿病预防计划中的二甲双胍治疗”[Metabolism (2016) 65;

DOI:
10.1016/j.metabol.2016.11.007
复制
发表时间:
2017
期刊:
Metabolism: clinical and experimental
影响因子:
--
通讯作者:
DiabetesPreventionProgramResearchGroup
DiabetesPreventionProgramResearchGroup
中科院分区:
--
文献类型:
--
作者:
Goldberg,RonaldB;Temprosa,Marinella;Mele,Lisa;Orchard,Trevor;Mather,Kieren;Bray,George;Horton,Edward;Kitabchi,Abbas;Krakoff,Jonathan;Marcovina,Santica;Perreault,Leigh;White,Neil;DiabetesPreventionProgramResearchGroup

文献摘要

相似文献

降脂药物(%)4.9%7.0%4.0%0.002甘油三酯(摩尔/L)1.6[1.1,2.3]1.6[1.1,2.2]1.7[1.2,2.4];0.001高密度脂蛋白胆固醇(摩尔/L)1.1[1.0,1.3]1.2[1.0,1.4]1.0[0.9,1.2]<0.001大型高密度脂蛋白-P(μ摩尔/L)⁎3.4[2.2,5.4]4.2[2.8,6.1]2.4[1.7,3.5]<0.001中型高密度脂蛋白-P(μ摩尔/L)⁎11[8.1,14.7]12.3[8.9,16.5]9.2[6.5,12]<0.001小高密度脂蛋白-P(μ摩尔/L)⁎19.1[16.1,22.3]18.5[15.4,21.9]20.1[17.3,22.9]<0.001总高密度脂蛋白-P(μ摩尔/L)⁎34.4[30.8,38.8]35.9[32.0,40.2]32.3[29.1,35.5]<0.001高密度脂蛋白尺寸(Nm)⁎8.8[8.6,9.1]8.8[8.7,9.2 8.6[8.5,8.8]<0.001脂联素(ng/ml)7.3[1.7,7.6]7.8[6.0,10.3]6.3[4.9,8.0]<纤维蛋白原(mg/dL)374.0[328.0,432.0]388.0[340.0,448.0]348.0[307.0,397.0];0.001 C反应蛋白(mg/L)3.7[1.7,7.6]5.0[2.5,9.2]2.0[0.9,3.8]<0.001白介素6(pg/ml)1.9[1.3,3.0]2.1[1.4,3.2]1.6[1.1,2.5]<0.001 mCP1(pg/ml)138.0[115.7,167.1]135.3[113.2,165.4]143.7[121.0,169.6]<0.001 sICAM(ng/ml)247.0[209.6,288.8]251.4[212.0,293.4]239.8[203.6,278.3]<0.001 sE选择素(ng/ml)44.0[32.9,56.7]43.7[32.3,56.2]44.5[34.2,57.7]0.046
Lipid-lowering meds (%) 4.9% 7.0% 4.0% 0.002 Triglyceride (mmol/L) 1.6 [1.1, 2.3] 1.6 [1.1, 2.2] 1.7 [1.2, 2.4]< 0.001 HDL-C (mmol/L) 1.1 [1.0, 1.3] 1.2 [1.0, 1.4] 1.0 [0.9, 1.2]< 0.001 Large HDL-P (μmol/L)⁎ 3.4 [2.2, 5.4] 4.2 [2.8, 6.1] 2.4 [1.7, 3.5]< 0.001 Medium HDL-P (μmol/L)⁎ 11 [8.1, 14.7] 12.3 [8.9, 16.5] 9.2 [6.5, 12]< 0.001 Small HDL-P (μmol/L)⁎ 19.1 [16.1, 22.3] 18.5 [15.4, 21.9] 20.1 [17.3, 22.9]< 0.001 Total HDL-P (μmol/L)⁎ 34.4 [30.8, 38.8] 35.9 [32.0, 40.2] 32.3 [29.1, 35.5]< 0.001 HDL size (nm)⁎ 8.8 [8.6, 9.1] 8.8 [8.7, 9.2 8.6 [8.5, 8.8]< 0.001 Adiponectin (ng/ml) 7.3 [1.7, 7.6] 7.8 [6.0, 10.3] 6.3 [4.9, 8.0]< 0.001 tPA (ng/ml) 10.9 [8.7, 13.4] 10.4 [8.3, 12.7] 12.0 [9.9, 14.6]< 0.001 Fibrinogen (mg/dL) 374.0 [328.0, 432.0] 388.0 [340.0, 448.0] 348.0 [307.0, 397.0]< 0.001 CRP (mg/L) 3.7 [1.7, 7.6] 5.0 [2.5, 9.2] 2.0 [0.9, 3.8]< 0.001 IL6 (pg/ml) 1.9 [1.3, 3.0] 2.1 [1.4, 3.2] 1.6 [1.1, 2.5]< 0.001 MCP1 (pg/ml) 138.0 [115.7, 167.1] 135.3 [113.2, 165.4] 143.7 [121.0, 169.6]< 0.001 sICAM (ng/ml) 247.0 [209.6, 288.8] 251.4 [212.0, 293.4] 239.8 [203.6, 278.3]< 0.001 sE selectin (ng/ml) 44.0 [32.9, 56.7] 43.7 [32.3, 56.2] 44.5 [34.2, 57.7] 0.046